tetrandrine has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Heister, PM; Poston, RN | 1 |
1 review(s) available for tetrandrine and Pneumonia, Viral
| Article | Year |
|---|---|
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.
Topics: Animals; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Calcium Channel Blockers; Calcium Channels; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Host-Pathogen Interactions; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Signal Transduction | 2020 |
1 other study(ies) available for tetrandrine and Pneumonia, Viral
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |